Richard D. Truesdell, Jr.

Davis Polk advised the underwriters in connection with the $487 million SEC-registered initial public offering by Legend Biotech Corporation of 21,188,750 American Depositary Shares, each…

Davis Polk advised the representative of the several underwriters in connection with an underwritten secondary offering of 14,130,523 shares of common stock of Werner Enterprises, Inc. by…

Davis Polk advised the joint book-running managers in connection with the $212 million SEC-registered follow-on offering of 2,995,757 shares of Class A common stock of Hamilton Lane…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by HubSpot, Inc. of $460 million aggregate principal amount of its 0.375% convertible senior notes due 2025…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Datadog, Inc. of $747.5 million aggregate principal amount of its 0.125%…

Davis Polk advised the representatives of the underwriters in connection with the $70 million follow-on public offering of 5,000,000 shares of common stock of TransMedics Group, Inc…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Under Armour, Inc. of $440 million aggregate principal amount of its 1.500%…

Davis Polk advised MSCI Inc. in connection with a Rule 144A/Regulation S offering of $1.0 billion aggregate principal amount of its 3.875% senior notes due 2031. The notes are guaranteed by…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Plug Power Inc. of $200 million aggregate principal amount of its 3.750%…

Davis Polk the initial purchasers in connection with a Rule 144A offering by Cantel Medical Corp. of $140 million principal amount of 3.250% convertible senior notes due 2025. Cantel’s…